Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150175 | SCV000197085 | likely benign | not specified | 2014-06-05 | criteria provided, single submitter | clinical testing | Pro77Leu in exon 2 of BAG3: This variant is not expected to have clinical signif icance due to a lack of conservation across species, including mammals. Of note, >45 mammals and other species have a leucine (Leu) at this position despite hig h nearby amino acid conservation. In addition, computational prediction tools do not suggest a high likelihood of impact to the protein. It has also been identi fied in 5/8600 European American chromosomes by the NHLBI Exome Sequencing Proje ct (http://evs.gs.washington.edu/EVS/; dbSNP rs141355480). |
Gene |
RCV001090931 | SCV000517070 | likely benign | not provided | 2020-12-04 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27042682) |
Invitae | RCV000472056 | SCV000550829 | likely benign | Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000150175 | SCV000612482 | benign | not specified | 2017-02-24 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852639 | SCV000995344 | likely benign | Cardiomyopathy | 2019-04-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001090931 | SCV001246713 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | BAG3: BP4, BS2 |
Ambry Genetics | RCV002444612 | SCV002734285 | likely benign | Cardiovascular phenotype | 2019-08-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000852639 | SCV003837857 | likely benign | Cardiomyopathy | 2022-03-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000150175 | SCV004099953 | benign | not specified | 2023-09-18 | criteria provided, single submitter | clinical testing | Variant summary: BAG3 c.230C>T (p.Pro77Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00026 in 251396 control chromosomes, predominantly at a frequency of 0.00047 within the Non-Finnish European subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 12-fold of the estimated maximal expected allele frequency for a pathogenic variant in BAG3 causing Dilated Cardiomyopathy phenotype (3.9e-05), strongly suggesting that the variant is a benign polymorphism. To our knowledge, no occurrence of c.230C>T in individuals affected with Dilated Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Diagnostic Laboratory, |
RCV001090931 | SCV001743599 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001090931 | SCV001924252 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001090931 | SCV001930648 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001090931 | SCV001955704 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001090931 | SCV001970630 | likely benign | not provided | no assertion criteria provided | clinical testing |